Gilead Sciences Ireland UC
ManufacturerNEW CHEMICAL ENTITY#100+Ranks are based on product registered in particular category, doesn't reflect the market position
Approved products
1
Best category rank
#100+
Updated
22 May 2026
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 1 | |
| 1 |
Product count1
Product count1
Rows per page:
1–2 of 2
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| Epclusa (sofosbuvir 400mg/ velpatasvir 100mg) Film-Coated Tablets | MAL18046002AZ | NEW CHEMICAL ENTITY | Gilead Sciences Malaysia Sdn. Bhd. | Gilead Sciences Ireland UC | DCH AURIGA (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
Epclusa (sofosbuvir 400mg/ velpatasvir 100mg) Film-Coated Tablets
Product Reg. noMAL18046002AZ
TypeNEW CHEMICAL ENTITY
Product HolderGilead Sciences Malaysia Sdn. Bhd.
ManufacturerGilead Sciences Ireland UC
ImporterDCH AURIGA (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–1 of 1